Please find enclosed herewith the Copy of News Paper Publication on the Audited Financial Results for the Q4 & FY 2025-26.
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GPT Healthcare Limited published its audited standalone financial results for Q4 and full year ended March 31, 2026 in newspapers on May 20, 2026. Total income from operations for Q4 FY26 stood at Rs 1,263.72 lakh, up about 24.6% from Rs 1,014.02 lakh in Q4 FY25. For the full year FY26, total income was Rs 4,725.47 lakh, rising roughly 16.1% from Rs 4,070.91 lakh in FY25. Net profit after tax for Q4 FY26 was Rs 144.72 lakh versus Rs 130.69 lakh in Q4 FY25. However, full-year net profit after tax declined to Rs 420.91 lakh from Rs 498.72 lakh in FY25. Earnings per share (basic) for FY26 was Rs 5.15 compared to Rs 6.08 in FY25. The results were reviewed by the Audit Committee and approved by the Board of Directors on May 19, 2026, and audited by statutory auditors under SEBI regulations.
The company showed strong revenue growth in both Q4 and full year, but full-year net profit declined year-on-year, indicating higher costs or lower margins. The EPS drop may create near-term pressure on investor sentiment despite the top-line growth.